• Something wrong with this record ?

Engineered N-acetylhexosamine-active enzymes in glycoscience

K. Slámová, P. Bojarová,

. 2017 ; 1861 (8) : 2070-2087. [pub] 20170327

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

BACKGROUND: In recent years, enzymes modifying N-acetylhexosamine substrates have emerged in numerous theoretical studies as well as practical applications from biology, biomedicine, and biotechnology. Advanced enzyme engineering techniques converted them into potent synthetic instruments affording a variety of valuable glycosides. SCOPE OF REVIEW: This review presents the diversity of engineered enzymes active with N-acetylhexosamine carbohydrates: from popular glycoside hydrolases and glycosyltransferases to less known oxidases, epimerases, kinases, sulfotransferases, and acetylases. Though hydrolases in natura, engineered chitinases, β-N-acetylhexosaminidases, and endo-β-N-acetylglucosaminidases were successfully employed in the synthesis of defined natural and derivatized chitooligomers and in the remodeling of N-glycosylation patterns of therapeutic antibodies. The genes of various N-acetylhexosaminyltransferases were cloned into metabolically engineered microorganisms for producing human milk oligosaccharides, Lewis X structures, and human-like glycoproteins. Moreover, mutant N-acetylhexosamine-active glycosyltransferases were applied, e.g., in the construction of glycomimetics and complex glycostructures, industrial production of low-lactose milk, and metabolic labeling of glycans. In the synthesis of biotechnologically important compounds, several innovative glycoengineered systems are presented for an efficient bioproduction of GlcNAc, UDP-GlcNAc, N-acetylneuraminic acid, and of defined glycosaminoglycans. MAJOR CONCLUSIONS: The above examples demonstrate that engineering of N-acetylhexosamine-active enzymes was able to solve complex issues such as synthesis of tailored human-like glycoproteins or industrial-scale production of desired oligosaccharides. Due to the specific catalytic mechanism, mutagenesis of these catalysts was often realized through rational solutions. GENERAL SIGNIFICANCE: Specific N-acetylhexosamine glycosylation is crucial in biological, biomedical and biotechnological applications and a good understanding of its details opens new possibilities in this fast developing area of glycoscience.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016699
003      
CZ-PrNML
005      
20190906121858.0
007      
ta
008      
180515s2017 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bbagen.2017.03.019 $2 doi
035    __
$a (PubMed)28347843
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Slámová, Kristýna $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ 14220 Prague 4, Czech Republic.
245    10
$a Engineered N-acetylhexosamine-active enzymes in glycoscience / $c K. Slámová, P. Bojarová,
520    9_
$a BACKGROUND: In recent years, enzymes modifying N-acetylhexosamine substrates have emerged in numerous theoretical studies as well as practical applications from biology, biomedicine, and biotechnology. Advanced enzyme engineering techniques converted them into potent synthetic instruments affording a variety of valuable glycosides. SCOPE OF REVIEW: This review presents the diversity of engineered enzymes active with N-acetylhexosamine carbohydrates: from popular glycoside hydrolases and glycosyltransferases to less known oxidases, epimerases, kinases, sulfotransferases, and acetylases. Though hydrolases in natura, engineered chitinases, β-N-acetylhexosaminidases, and endo-β-N-acetylglucosaminidases were successfully employed in the synthesis of defined natural and derivatized chitooligomers and in the remodeling of N-glycosylation patterns of therapeutic antibodies. The genes of various N-acetylhexosaminyltransferases were cloned into metabolically engineered microorganisms for producing human milk oligosaccharides, Lewis X structures, and human-like glycoproteins. Moreover, mutant N-acetylhexosamine-active glycosyltransferases were applied, e.g., in the construction of glycomimetics and complex glycostructures, industrial production of low-lactose milk, and metabolic labeling of glycans. In the synthesis of biotechnologically important compounds, several innovative glycoengineered systems are presented for an efficient bioproduction of GlcNAc, UDP-GlcNAc, N-acetylneuraminic acid, and of defined glycosaminoglycans. MAJOR CONCLUSIONS: The above examples demonstrate that engineering of N-acetylhexosamine-active enzymes was able to solve complex issues such as synthesis of tailored human-like glycoproteins or industrial-scale production of desired oligosaccharides. Due to the specific catalytic mechanism, mutagenesis of these catalysts was often realized through rational solutions. GENERAL SIGNIFICANCE: Specific N-acetylhexosamine glycosylation is crucial in biological, biomedical and biotechnological applications and a good understanding of its details opens new possibilities in this fast developing area of glycoscience.
650    _2
$a katalýza $7 D002384
650    _2
$a glykoproteiny $x biosyntéza $7 D006023
650    _2
$a glykosidhydrolasy $x metabolismus $7 D006026
650    _2
$a glykosylace $7 D006031
650    _2
$a glykosyltransferasy $x metabolismus $7 D016695
650    _2
$a hexosaminy $x metabolismus $7 D006595
650    _2
$a oligosacharidy $x biosyntéza $7 D009844
650    12
$a proteinové inženýrství $7 D015202
650    _2
$a sulfotransferasy $x metabolismus $7 D015238
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Bojarová, Pavla $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ 14220 Prague 4, Czech Republic. Electronic address: bojarova@biomed.cas.cz.
773    0_
$w MED00000717 $t Biochimica et biophysica acta. G, General subjects $x 0304-4165 $g Roč. 1861, č. 8 (2017), s. 2070-2087
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28347843 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20190906122231 $b ABA008
999    __
$a ok $b bmc $g 1300323 $s 1013539
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 1861 $c 8 $d 2070-2087 $e 20170327 $i 0304-4165 $m Biochimica et biophysica acta. G, General subjects $n Biochem Biophys Acta $x MED00000717
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...